$HOL $ASTR Big Week
Been a bull in this company, but with it hitting the $10 range I did buy some at 10.02 and Friday bought more at 10.77. This week in Holicity/Astra is pretty massive and I believe the upside out weighs the risk. With getting about a 480mil on their balance sheet, this gives a somewhat fair value of $13, which at current price would be about 20% move this week or even more depending on other factors.
News
-Merger is this week on June 30th and Ticker change on July 1st to ticker "ASTR"
-Astra acquired Apollo Fusion, which will give Astra a boost in their Thursters. This will help low orbit and other orbits of Earth while also giving the possibility of sendings their Rockets too the Moon for SATS according to the interview with Astra and Apollo Fusion.
-Has Planet Contract to send SATS
-Was awarded the TROPIC NASA contract, which starts in Q1 of 2022
-Their monthly rocket will be ready around Q4
-Pipe investors can't sell in a 6 month period. Warrents are exchange at $10, not sure on the deadline.
TA: I know the news sounds amazing and theres more to come like the ANN of the summer launch, which no date is available at the time of writing this. It's suppose to launch this Summer.
-Prime Target in the short term is $13.
-Sideways movement is between the zones of 10.76-11.05. Below 10.76 is key buying and above 11.05 is lots of sellers.
-RSI is oversold and could see a bounce Monday with merger coming soon.
-MACD is looking to flip Bullish
-VPVR levels 10.84-10.90 with next high vpvr levels being in our trading zone of sellers. if we break above 11.26 next level is 11.37 than 12.28
-EMA's are consoldating, but squeezing suggesting a pretty big move ahead.
Final Thoughts:
I'm bullish on this stock in the short term and long term with it hitting my value of investing. Does the company make it cheap? Does the company help others? Who are they competing with? The last question is just 1 which is Rocket Labs, yet they failed to get the NASA Contract due to it not being cheap to use. ASTRA is a game changer and will only get better, but also tougher as other companies try to do it better and cheaper than them. As of now this stock is a buy in the short and long term.
News
-Merger is this week on June 30th and Ticker change on July 1st to ticker "ASTR"
-Astra acquired Apollo Fusion, which will give Astra a boost in their Thursters. This will help low orbit and other orbits of Earth while also giving the possibility of sendings their Rockets too the Moon for SATS according to the interview with Astra and Apollo Fusion.
-Has Planet Contract to send SATS
-Was awarded the TROPIC NASA contract, which starts in Q1 of 2022
-Their monthly rocket will be ready around Q4
-Pipe investors can't sell in a 6 month period. Warrents are exchange at $10, not sure on the deadline.
TA: I know the news sounds amazing and theres more to come like the ANN of the summer launch, which no date is available at the time of writing this. It's suppose to launch this Summer.
-Prime Target in the short term is $13.
-Sideways movement is between the zones of 10.76-11.05. Below 10.76 is key buying and above 11.05 is lots of sellers.
-RSI is oversold and could see a bounce Monday with merger coming soon.
-MACD is looking to flip Bullish
-VPVR levels 10.84-10.90 with next high vpvr levels being in our trading zone of sellers. if we break above 11.26 next level is 11.37 than 12.28
-EMA's are consoldating, but squeezing suggesting a pretty big move ahead.
Final Thoughts:
I'm bullish on this stock in the short term and long term with it hitting my value of investing. Does the company make it cheap? Does the company help others? Who are they competing with? The last question is just 1 which is Rocket Labs, yet they failed to get the NASA Contract due to it not being cheap to use. ASTRA is a game changer and will only get better, but also tougher as other companies try to do it better and cheaper than them. As of now this stock is a buy in the short and long term.
Related publications
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.